Microbiomes in Patients of Recurrent Common Bile Duct Stones
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03102281|
Recruitment Status : Unknown
Verified March 2017 by The Second Hospital of Nanjing Medical University.
Recruitment status was: Recruiting
First Posted : April 5, 2017
Last Update Posted : April 5, 2017
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Gastrointestinal Microbiomes in Patients of Recurrent Common Bile Duct Stones After Endoscopic Sphincterotomy（EST）|
|Estimated Study Start Date :||May 1, 2017|
|Estimated Primary Completion Date :||March 31, 2020|
|Estimated Study Completion Date :||March 31, 2020|
Patients who had recurrent common bile duct stones.
Patients who had not recurrent common bile duct stones.
- Changes of Bacteria in Body Fluid [ Time Frame: 3 years ]measure the changes of Bacteria in Body Fluid
- Stone diameter [ Time Frame: 3 years ]measure the stone diameter
- EST size [ Time Frame: 3 years ]measure the EST size
- Stone type [ Time Frame: 3 years ]test the stone type
- Bile acid composition(Mass spectrometry or Chromatography) [ Time Frame: 3 years ]measure the bile acid composition with Mass spectrometry or Chromatography
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03102281
|Contact: Miao Linfirstname.lastname@example.org|
|Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University||Recruiting|
|Nanjing, Jiangsu, China, 210011|
|Contact: Lin Miao, MD 086-25-58509932 email@example.com|
|Principal Investigator:||Miao Lin, Study Principal Investigator||Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University|